Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An update from Chaoju Eye Care Holdings Ltd. ( (HK:2219) ) is now available.
Chaoju Eye Care reported a 3.2% decline in 2025 revenue to RMB1.36 billion and a 4.7% drop in net profit to RMB177.4 million, with net margin edging down to 13.0% despite a slightly higher pre-tax margin. Non-IFRS adjusted net profit also weakened, while basic earnings per share fell to RMB0.26, underscoring pressure on profitability.
Operationally, the group expanded its network to 31 ophthalmic hospitals and 32 optical centers, adding three optical centers year-on-year. The board proposed a final dividend of HK$0.2423 per share for 2025, signaling continued capital returns to shareholders despite softer earnings and margin compression.
The most recent analyst rating on (HK:2219) stock is a Hold with a HK$3.00 price target. To see the full list of analyst forecasts on Chaoju Eye Care Holdings Ltd. stock, see the HK:2219 Stock Forecast page.
More about Chaoju Eye Care Holdings Ltd.
Chaoju Eye Care Holdings Ltd. is a China-based ophthalmic medical services provider operating ophthalmic hospitals and optical centers. The group focuses on eye care treatments and related optical services, expanding its network of hospitals and retail optical outlets to serve patients across its regional markets.
Average Trading Volume: 423,460
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$1.83B
Learn more about 2219 stock on TipRanks’ Stock Analysis page.